Brief: Design Therapeutics Q1 Basic EPS USD -0.2
08/05/2024 21:05
May 08 (Reuters) - Design Therapeutics Q1 operating expenses USD 14.4 million. * Q1 operating income USD -14.4 million * Q1 net income USD -11.105 million
Recent news on Design Therapeutics
See all newsDesign Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Design Therapeutics Q2 net loss narrower than expected
Brief: Design Therapeutics Q2 Basic EPS USD -0.32
Design Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Design Therapeutics Announces Initiation Of Patient Dosing In Phase 1 Multiple Ascending Dose Trial Of Dt-818 For Myotonic Dystrophy Type-1